Expanding Clinical Experience With Istradefylline in <scp> <i>ADCY5</i> </scp> ‐Related Movement Disorder: A Case With No Benefit
The data that support the findings of this study are available from the corresponding author upon reasonable request. Data S1. Coi_Disclosure. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Authors
- Kathryn Yang (ORCID: https://orcid.org/0009-0004-6892-5189)
- Katerina Bernardi (ORCID: https://orcid.org/0009-0004-3387-7623)
- Darius Ebrahimi-Fakhari
Institutions
- Boston Children's Hospital (US)
Publication Details
- Journal
- Movement Disorders Clinical Practice
- Published
- 2026-02-25
- DOI
- https://doi.org/10.1002/mdc3.70572
- Primary Topic
- Neurological and metabolic disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00